搜尋
市場行情
自選股
新聞
分析
交易工具
選股工具
掃碼下載
一鍵診股 讓投資更聰明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登入
免費註冊
搜尋
免費註冊
市場行情
/
股票
/
醫藥與醫學研究
/
藥品
/
eypt
/
財務摘要
EyePoint Pharmaceuticals Inc
EYPT
添加自選
4.250
USD
+0.020
+0.47%
收盤 09-11 16:00(美東)
361.17M
總市值
虧損
本益比TTM
EyePoint Pharmaceuticals Inc
4.250
+0.020
+0.47%
概覽
新聞分析
財務
股票評分
技術分析
預測
持股情況
股息
公司資料
財務摘要
利潤表
資產負債表
現金流量表
公司收入
財報
公司估值
風險評估
概覽
新聞分析
財務
股票評分
技術分析
預測
持股情況
股息
公司資料
財務摘要
利潤表
資產負債表
現金流量表
公司收入
財報
公司估值
風險評估
EYPT 財務數據
透過專為投資者打造的一站式數據看板,全面查看 EyePoint Pharmaceuticals Inc 的財務狀況。平台將複雜的財務報表整理為可自定義的視圖,助您更輕鬆地進行財務分析。您可以查看最新年度財務報告,也可以通過利潤表、資產負債表和現金流量表,按季度分析公司表現。借助實時財務指標,持續追蹤公司的經營狀況和市場表現更加便捷。
關鍵財務比率
總市值
361.17M
股利TTM
0.00
本益比TTM
-1.21
每股盈餘TTM
-3.51
營業收入
31.37M
淨利潤
-130.87M
淨資產收益率
-102.71%
總資產收益率
-83.47%
EyePoint Pharmaceuticals Inc 財報行事曆
最新發布
8月 5, 2026
每股收益 / 預測值
-1.09
/-0.95
營業收入 / 預測值
507.00K
/406.86K
財務報表摘要
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
財務指標
每股收益
-28.45%
-1.09
-52.27%
-0.99
-26.92%
-0.81
-57.86%
-0.85
-46.68%
-0.85
-17.05%
-0.65
-91.79%
-0.64
-63.93%
-0.54
5.02%
-0.58
1.97%
-0.55
71.28%
-0.33
--
-0.33
--
-0.61
--
-0.56
--
-1.16
--
-1.58
--
--
--
--
--
--
--
--
營業收入
-90.49%
507.00K
-97.15%
696.00K
-94.65%
620.00K
-90.82%
966.00K
-43.73%
5.33M
109.29%
24.45M
-17.39%
11.59M
-30.77%
10.52M
4.09%
9.48M
52.08%
11.68M
33.18%
14.03M
51.84%
15.20M
-21.27%
9.11M
-17.33%
7.68M
-8.76%
10.53M
10.52%
10.01M
28.31%
11.56M
26.92%
9.29M
61.88%
11.54M
-42.28%
9.06M
淨利潤
-58.97%
-94.47M
-87.70%
-84.83M
-63.31%
-67.61M
-103.44%
-59.73M
-92.78%
-59.43M
-54.33%
-45.20M
-193.63%
-41.40M
-132.80%
-29.36M
-34.49%
-30.83M
-38.37%
-29.28M
67.55%
-14.10M
31.53%
-12.61M
-18.11%
-22.92M
-0.90%
-21.16M
-123.61%
-43.45M
-10.33%
-18.42M
-93.87%
-19.41M
-70.81%
-20.98M
-25.62%
-19.43M
-339.23%
-16.70M
利潤率
-1572.17%
-18633.14%
-6494.66%
-12188.51%
-2952.33%
-10904.68%
-2116.36%
-6183.44%
-242.58%
-1114.31%
26.26%
-184.82%
-255.46%
-357.26%
-236.28%
-278.99%
-29.21%
-325.27%
9.01%
-250.63%
75.64%
-100.51%
--
-82.96%
--
-251.73%
--
-275.47%
--
-412.53%
--
-190.48%
--
--
--
--
--
--
--
--
毛利率
3.19%
100.00%
-75.04%
24.14%
-57.49%
39.52%
-72.73%
25.36%
13.72%
96.91%
3.43%
96.71%
0.08%
92.96%
0.99%
93.01%
6.10%
85.22%
2.00%
93.50%
41.42%
92.89%
--
92.09%
--
80.32%
--
91.67%
--
65.68%
--
78.10%
--
--
--
--
--
--
--
--
資產負債率
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-100.00%
0.00%
--
0.00%
--
0.00%
--
22.42%
--
22.08%
--
18.05%
--
--
--
--
--
--
--
--
利潤表
營業收入
-90.49%
507.00K
-97.15%
696.00K
-94.65%
620.00K
-90.82%
966.00K
-43.73%
5.33M
109.29%
24.45M
-17.39%
11.59M
-30.77%
10.52M
4.09%
9.48M
52.08%
11.68M
33.18%
14.03M
51.84%
15.20M
-21.27%
9.11M
-17.33%
7.68M
-8.76%
10.53M
10.52%
10.01M
28.31%
11.56M
26.92%
9.29M
61.88%
11.54M
-42.28%
9.06M
營業利潤
-56.49%
-97.38M
-78.61%
-87.23M
-55.50%
-70.34M
-89.40%
-62.02M
-80.13%
-62.23M
-46.57%
-48.84M
-176.62%
-45.24M
-127.45%
-32.75M
-51.78%
-34.55M
-54.59%
-33.32M
29.01%
-16.35M
21.74%
-14.40M
-18.45%
-22.76M
-17.88%
-21.55M
-27.62%
-23.04M
-20.15%
-18.40M
-75.03%
-19.22M
-67.21%
-18.28M
-41.71%
-18.05M
-682.47%
-15.31M
淨利潤
-58.97%
-94.47M
-87.70%
-84.83M
-63.31%
-67.61M
-103.44%
-59.73M
-92.78%
-59.43M
-54.33%
-45.20M
-193.63%
-41.40M
-132.80%
-29.36M
-34.49%
-30.83M
-38.37%
-29.28M
67.55%
-14.10M
31.53%
-12.61M
-18.11%
-22.92M
-0.90%
-21.16M
-123.61%
-43.45M
-10.33%
-18.42M
-93.87%
-19.41M
-70.81%
-20.98M
-25.62%
-19.43M
-339.23%
-16.70M
資產負債表
流動資產
-28.82%
188.82M
-23.70%
249.50M
-14.26%
328.65M
-19.53%
216.11M
-10.06%
265.25M
2.92%
326.98M
11.17%
383.31M
78.84%
268.55M
76.48%
294.93M
117.52%
317.71M
99.53%
344.80M
-21.83%
150.16M
-18.82%
167.12M
-33.50%
146.06M
-27.31%
172.81M
35.50%
192.10M
35.59%
205.87M
37.83%
219.63M
276.67%
237.75M
197.90%
141.78M
流動負債總額
26.43%
41.94M
-10.12%
37.46M
-24.51%
37.02M
-38.32%
30.09M
-46.58%
33.17M
-33.40%
41.68M
-22.47%
49.05M
-23.64%
48.79M
-9.89%
62.10M
129.72%
62.58M
83.17%
63.26M
86.52%
63.90M
106.40%
68.92M
-14.79%
27.24M
45.98%
34.54M
71.86%
34.26M
105.48%
33.39M
137.86%
31.97M
58.91%
23.66M
54.20%
19.93M
總資產
-24.23%
228.19M
-20.51%
288.22M
-13.02%
364.00M
-16.36%
251.69M
-7.12%
301.15M
10.12%
362.56M
17.82%
418.46M
88.02%
300.92M
84.59%
324.25M
112.98%
329.25M
96.93%
355.18M
-27.41%
160.04M
-24.75%
175.66M
-36.79%
154.59M
-31.52%
180.36M
31.05%
220.49M
30.54%
233.43M
30.68%
244.56M
187.16%
263.37M
119.10%
168.25M
總負債
12.05%
61.78M
-10.01%
57.74M
-29.38%
57.88M
-37.32%
51.51M
-42.53%
55.14M
-19.10%
64.17M
-7.76%
81.96M
-18.97%
82.18M
-18.96%
95.94M
4.08%
79.31M
5.80%
88.86M
20.54%
101.42M
44.26%
118.39M
-1.97%
76.20M
6.32%
83.99M
11.44%
84.14M
14.05%
82.07M
8.82%
77.74M
7.95%
78.99M
9.11%
75.50M
總權益
-32.36%
166.41M
-22.76%
230.47M
-9.03%
306.11M
-8.48%
200.18M
7.75%
246.01M
19.39%
298.40M
26.35%
336.50M
273.13%
218.73M
298.70%
228.31M
218.83%
249.93M
176.36%
266.32M
-57.01%
58.62M
-62.17%
57.26M
-53.01%
78.39M
-47.73%
96.37M
47.01%
136.35M
41.64%
151.37M
44.17%
166.82M
894.44%
184.38M
1121.33%
92.75M
現金流量表
經營淨額
0.39%
-62.35M
-51.64%
-80.55M
-81.45%
-65.05M
-52.08%
-59.35M
-210.18%
-62.59M
-70.41%
-53.12M
-55.13%
-35.85M
-156.70%
-39.03M
-135.39%
-20.18M
-85.16%
-31.17M
-83.58%
-23.11M
-15.74%
-15.20M
398.19%
57.02M
16.48%
-16.84M
24.48%
-12.59M
-68.69%
-13.14M
-81.38%
-19.12M
-33.51%
-20.16M
-382.75%
-16.67M
-785.48%
-7.79M
投資淨額
55.37%
75.10M
49.41%
59.05M
22.19%
-74.67M
241.97%
55.38M
130.14%
48.34M
89.97%
39.52M
-103.53%
-95.96M
1041.63%
16.20M
-1291.02%
-160.40M
-35.16%
20.81M
-243.23%
-47.15M
-127.42%
-1.72M
112325.00%
13.47M
156.85%
32.09M
199.85%
32.92M
4887.79%
6.27M
52.00%
-12.00K
--
-56.44M
-17069.27%
-32.97M
-2.34%
-131.00K
融資淨額
8300.00%
19.99M
-174.87%
-2.61M
10.07%
166.96M
-37.75%
7.40M
-27.66%
238.00K
-926.96%
-951.00K
-30.57%
151.69M
14.78%
11.89M
100.90%
329.00K
102.25%
115.00K
376798.28%
218.49M
11163.04%
10.36M
-13181.88%
-36.66M
-1042.63%
-5.12M
-100.05%
-58.00K
4700.00%
92.00K
27.56%
-276.00K
-100.41%
-448.00K
935.46%
108.52M
-100.04%
-2.00K
營業收入
業務
報告期:
暫無數據
地區
報告期:
暫無數據
常見問題
EyePoint Pharmaceuticals Inc的總收入是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,總收入達到31.37M(同比變化43.27M)。
EyePoint Pharmaceuticals Inc的流動資產是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,流動資產為328.65M(同比變化-14.26)。
EyePoint Pharmaceuticals Inc的總資產是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,EyePoint Pharmaceuticals Inc的總資產為364.00M(同比變化-13.02)。
EyePoint Pharmaceuticals Inc的總負債是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,EyePoint Pharmaceuticals Inc的總責任為57.88M(同比變化-29.38)。
EyePoint Pharmaceuticals Inc的總權益是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,EyePoint Pharmaceuticals Inc的總權益為306.11M(同比變化-9.03)。
EyePoint Pharmaceuticals Inc的淨營業收入是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,EyePoint Pharmaceuticals Inc的淨營業收入為-243.43M(同比變化-66.90)。
EyePoint Pharmaceuticals Inc的淨投資是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,EyePoint Pharmaceuticals Inc的淨投資為68.58M(同比變化131.26)。
EyePoint Pharmaceuticals Inc的淨融資是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,EyePoint Pharmaceuticals Inc的淨融資為173.65M(同比變化5.87)。
EyePoint Pharmaceuticals Inc的每股收益(EPS)是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,每股收益(EPS)為-3.17(同比變化-36.22)。
EyePoint Pharmaceuticals Inc的淨利潤是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,淨利潤為-231.96M(同比變化-77.25)。
EyePoint Pharmaceuticals Inc的淨利潤率是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,淨利潤率為-739.42(同比變化-144.49)。
EyePoint Pharmaceuticals Inc的毛利率是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,毛利率為93.41(同比變化2.18)。
EyePoint Pharmaceuticals Inc的股東權益回報率(ROE)是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,股東權益回報率(ROE)為-72.19(同比變化-66.27)。
EyePoint Pharmaceuticals Inc的資產回報率(ROA)是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,資產回報率(ROA)為-59.29(同比變化-75.25)。
EyePoint Pharmaceuticals Inc的營業利潤是多少?
根據EyePoint Pharmaceuticals Inc的FY2025財報,營業利潤為-243.43M(同比變化-66.90)。